PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 35132703-0 2022 Eugenol restrains abdominal aortic aneurysm progression with down-regulations on NF-kappaB and COX-2. Eugenol 0-7 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus 81-90 35132703-7 2022 After elucidation the efficiency of eugenol against AAA progression by AAA diameter, hematoxylin-eosin staining and orcein staining, the down-regulations of eugenol on COX-2 and NF-kappaB were further detected by immunohistochemistry and western blot. Eugenol 157-164 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus 178-187 35132703-9 2022 Excellent efficiency, high oral bioavailability and down-regulation on COX-2/NF-kappaB endowed eugenol great potential for future AAA therapy. Eugenol 95-102 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus 77-86 20075264-1 2010 Eugenol, a methoxyphenol component of clove oil, suppresses cyclooxygenase-2 expression, while eugenol dimers prevent nuclear factor-kappaB (NF-kappaB) activation and inflammatory cytokine expression in lipopolysaccharide-stimulated macrophages. Eugenol 95-102 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus 141-150 29126931-10 2018 Taken together, our findings suggest that allylguaiacol exerts a neuroprotective effect through the antioxidant activation and protein regulation of NF-kappaB p65 and DAXX-related signaling. Eugenol 42-55 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus 149-158 25588851-0 2015 Antiasthmatic Effects of Eugenol in a Mouse Model of Allergic Asthma by Regulation of Vitamin D3 Upregulated Protein 1/NF-kappaB Pathway. Eugenol 25-32 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus 119-128 33059262-0 2020 Anterior gradient 2 is a novel pro-tumor factor in pancreatic cancer under NF-kappaB subunit RelA trans-regulation that can be suppressed by eugenic acid. Eugenol 141-153 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus 75-84 23160676-0 2012 Comparative inhibitory effects of magnolol, honokiol, eugenol and bis-eugenol on cyclooxygenase-2 expression and nuclear factor-kappa B activation in RAW264.7 macrophage-like cells stimulated with fimbriae of Porphyromonas gingivalis. Eugenol 54-61 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus 113-135 23160676-10 2012 Both the fimbria-stimulated binding of NF-kappaB to its consensus sequence and phosphorylation-dependent proteolysis of inhibitor kappaB-alpha were markedly inhibited by magnilol and honokiol, whereas eugenol and bis-eugenol did not inhibit COX-2 expression and NF-kappaB activation. Eugenol 201-208 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus 39-48 12963494-5 2003 We observed that bis-eugenol, but not eugenol, clearly inhibited the degradation of inhibitory kappa B-alpha in RAW264.7 murine macrophages stimulated with lipopolysaccharide and, consequently, the transcriptional activity of the stimulated NF-kappa B in the cells. Eugenol 21-28 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus 241-251 17698059-8 2007 The isoeugenol analogues eugenol and allylbenzene also inhibited LPS-induced NF-kappaB signaling and iNOS expression, albeit with less potency than isoeugenol. Eugenol 7-14 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus 77-86